Armata Pharmaceuticals, Inc.
Company Stats
- Market Cap
- $136.5M
- as of Sep 30, 2026
- Shares Outstanding
- 37.2M
- Free Float
- 99.4%
Income Statement
- Operating Income
- -$36.6M
- Net Income
- -$173.8M
- EBITDA
- -$35.1M
Cash Flow
- Free Cash Flow
- -$26.3M
- FCF Yield
- -19.3%
- Owner FCF Yield
- -21.2%
Balance Sheet
- Cash & Equivalents
- $8.7M
Returns & Capital
- SBC, 3Y Avg
- $2.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$26.3M | — |
| FY2024 | — | -$39.4M | — |
| FY2023 | — | -$55.6M | — |
| FY2022 | — | -$34.7M | — |
| FY2021 | — | -$24.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 25, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges